Michael A. Kiselow

795 total citations
17 papers, 388 citations indexed

About

Michael A. Kiselow is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Surgery. According to data from OpenAlex, Michael A. Kiselow has authored 17 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Small Animals and 4 papers in Surgery. Recurrent topics in Michael A. Kiselow's work include Veterinary Oncology Research (14 papers), Infectious Diseases and Mycology (8 papers) and Virus-based gene therapy research (3 papers). Michael A. Kiselow is often cited by papers focused on Veterinary Oncology Research (14 papers), Infectious Diseases and Mycology (8 papers) and Virus-based gene therapy research (3 papers). Michael A. Kiselow collaborates with scholars based in United States, United Kingdom and Tanzania. Michael A. Kiselow's co-authors include Kenneth M. Rassnick, Andrea B. Flory, Dennis B. Bailey, Cheryl E. Balkman, Hollis N. Erb, Joanne L. Intile, Kenneth W. Simpson, Richard E. Goldstein, Sean P. McDonough and David Russell and has published in prestigious journals such as Journal of the American Veterinary Medical Association, Journal of Veterinary Internal Medicine and American Journal of Veterinary Research.

In The Last Decade

Michael A. Kiselow

17 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Kiselow United States 9 333 214 140 54 54 17 388
Andrea B. Flory United States 12 397 1.2× 248 1.2× 162 1.2× 68 1.3× 54 1.0× 20 438
John D. Chretin United States 11 306 0.9× 188 0.9× 106 0.8× 58 1.1× 37 0.7× 18 391
Paola Valenti Italy 9 303 0.9× 177 0.8× 70 0.5× 42 0.8× 36 0.7× 24 353
Carrie A. Wood United States 7 295 0.9× 157 0.7× 155 1.1× 45 0.8× 30 0.6× 12 330
Susan Plaza United States 7 305 0.9× 105 0.5× 114 0.8× 33 0.6× 46 0.9× 7 375
Vanessa Turinelli France 6 322 1.0× 206 1.0× 145 1.0× 68 1.3× 61 1.1× 13 394
Deborah A. L'Heureux United States 8 365 1.1× 225 1.1× 211 1.5× 63 1.2× 35 0.6× 8 414
Leifer Ce 8 145 0.4× 66 0.3× 65 0.5× 20 0.4× 36 0.7× 10 307
Lavinia E. Chiti Italy 9 226 0.7× 159 0.7× 14 0.1× 20 0.4× 20 0.4× 32 278
Brad J. Davis United States 8 36 0.1× 59 0.3× 9 0.1× 4 0.1× 31 0.6× 9 306

Countries citing papers authored by Michael A. Kiselow

Since Specialization
Citations

This map shows the geographic impact of Michael A. Kiselow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Kiselow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Kiselow more than expected).

Fields of papers citing papers by Michael A. Kiselow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Kiselow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Kiselow. The network helps show where Michael A. Kiselow may publish in the future.

Co-authorship network of co-authors of Michael A. Kiselow

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Kiselow. A scholar is included among the top collaborators of Michael A. Kiselow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Kiselow. Michael A. Kiselow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rassnick, Kenneth M., Dennis B. Bailey, Debra A. Kamstock, et al.. (2021). Survival time for dogs with previously untreated, peripheral nodal, intermediate- or large-cell lymphoma treated with prednisone alone: the Canine Lymphoma Steroid Only trial. Journal of the American Veterinary Medical Association. 259(1). 62–71. 4 indexed citations
2.
Kiselow, Michael A.. (2019). Private Practice Oncology. Veterinary Clinics of North America Small Animal Practice. 49(3). 519–527. 2 indexed citations
3.
Rassnick, Kenneth M., et al.. (2014). Tolerability of Lomustine in Combination with Cyclophosphamide in Dogs with Lymphoma. Journal of the American Animal Hospital Association. 50(3). 167–173. 7 indexed citations
4.
Gieger, Tracy L., et al.. (2013). Reirradiation of Canine Nasal Carcinomas Treated with Coarsely Fractionated Radiation Protocols: 37 Cases. Journal of the American Animal Hospital Association. 49(5). 318–324. 9 indexed citations
5.
Balkman, Cheryl E., Michael A. Kiselow, Andrea B. Flory, et al.. (2012). Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer. Veterinary and Comparative Oncology. 12(2). 160–168. 2 indexed citations
6.
Rassnick, Kenneth M., et al.. (2011). Comparison of two questionnaires to assess gastrointestinal toxicity in dogs and cats treated with chemotherapy*. Veterinary and Comparative Oncology. 9(3). 225–231. 4 indexed citations
7.
Rassnick, Kenneth M., Antony S. Moore, David Russell, et al.. (2010). Phase II, Open-Label Trial of Single-Agent CCNU in Dogs with Previously Untreated Histiocytic Sarcoma. Journal of Veterinary Internal Medicine. 24(6). 1528–1531. 55 indexed citations
8.
Rassnick, Kenneth M., Dennis B. Bailey, Joanne L. Intile, et al.. (2010). Comparison between l-CHOP and an l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) for lymphoma in dogs. Veterinary and Comparative Oncology. 8(4). 243–253. 32 indexed citations
9.
Rassnick, Kenneth M., Dennis B. Bailey, David Russell, et al.. (2010). A phase II study to evaluate the toxicity and efficacy of alternating CCNU and high-dose vinblastine and prednisone (CVP) for treatment of dogs with high-grade, metastatic or nonresectable mast cell tumours. Veterinary and Comparative Oncology. 8(2). 138–152. 35 indexed citations
10.
Intile, Joanne L., Kenneth M. Rassnick, Dennis B. Bailey, et al.. (2009). Evaluation of dexamethasone as a chemoprotectant for CCNU‐induced bone marrow suppression in dogs*. Veterinary and Comparative Oncology. 7(1). 69–77. 7 indexed citations
11.
Rassnick, Kenneth M., Dennis B. Bailey, Andrea B. Flory, et al.. (2008). Efficacy of Vinblastine for Treatment of Canine Mast Cell Tumors. Journal of Veterinary Internal Medicine. 22(6). 1390–1396. 34 indexed citations
12.
Flory, Andrea B., Kenneth M. Rassnick, Cheryl E. Balkman, et al.. (2008). Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs. American Journal of Veterinary Research. 69(10). 1316–1322. 12 indexed citations
13.
Flory, Andrea B., Kenneth M. Rassnick, Renée Al-Sarraf, et al.. (2008). Combination of CCNU and DTIC Chemotherapy for Treatment of Resistant Lymphoma in Dogs. Journal of Veterinary Internal Medicine. 22(1). 164–171. 40 indexed citations
14.
Kiselow, Michael A., Kenneth M. Rassnick, Sean P. McDonough, et al.. (2008). Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995–2005). Journal of the American Veterinary Medical Association. 232(3). 405–410. 94 indexed citations
15.
Flory, Andrea B., Kenneth M. Rassnick, Cheryl E. Balkman, et al.. (2008). Oral bioavailability of etoposide after administration of a single dose to tumor-bearing dogs. Journal of the American Veterinary Medical Association. 233(8). 1277–1277. 1 indexed citations
16.
Rassnick, Kenneth M., Margaret C. McEntee, Hollis N. Erb, et al.. (2007). Comparison of 3 Protocols for Treatment after Induction of Remission in Dogs with Lymphoma. Journal of Veterinary Internal Medicine. 21(6). 1364–1373. 42 indexed citations
17.
Rassnick, Kenneth M., Margaret C. McEntee, Hollis N. Erb, et al.. (2007). Comparison of 3 Protocols for Treatment after Induction of Remission in Dogs with Lymphoma. Journal of Veterinary Internal Medicine. 21(6). 1364–1364. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026